Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies
Stephanie Vauleon, Katharina Schutz, Benoit Massonnet, Nanda Gruben, Marianne Manchester, Alessandra Buehler, Eginhard Schick, Lauren Boak, David J Hawellek
doi: https://doi.org/10.1101/2022.07.22.22277927
Stephanie Vauleon
1Regulated Bioanalysis, Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
Katharina Schutz
1Regulated Bioanalysis, Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
Benoit Massonnet
1Regulated Bioanalysis, Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
Nanda Gruben
2ICON Bioanalytical Laboratories, Assen, The Netherlands
Marianne Manchester
3Pharmaceutical Sciences, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
Alessandra Buehler
1Regulated Bioanalysis, Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
Eginhard Schick
1Regulated Bioanalysis, Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
Lauren Boak
4F. Hoffmann-La Roche Ltd, Basel, Switzerland
David J Hawellek
5Biomarkers & Translational Technologies, Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Posted July 22, 2022.
Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies
Stephanie Vauleon, Katharina Schutz, Benoit Massonnet, Nanda Gruben, Marianne Manchester, Alessandra Buehler, Eginhard Schick, Lauren Boak, David J Hawellek
medRxiv 2022.07.22.22277927; doi: https://doi.org/10.1101/2022.07.22.22277927
Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies
Stephanie Vauleon, Katharina Schutz, Benoit Massonnet, Nanda Gruben, Marianne Manchester, Alessandra Buehler, Eginhard Schick, Lauren Boak, David J Hawellek
medRxiv 2022.07.22.22277927; doi: https://doi.org/10.1101/2022.07.22.22277927
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2973)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12829)
- Forensic Medicine (12)
- Gastroenterology (834)
- Genetic and Genomic Medicine (4627)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2946)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4423)
- Nursing (238)
- Nutrition (653)
- Oncology (2299)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7014)
- Radiology and Imaging (1551)
- Respiratory Medicine (923)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (213)
- Urology (185)